🇨🇦 Glargine Basal-Bolus Therapy in Canada

Glargine Basal-Bolus Therapy (Glargine Basal-Bolus Therapy) regulatory status in Canada.

Marketing authorisation

Glargine Basal-Bolus Therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Glargine Basal-Bolus Therapy approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Glargine Basal-Bolus Therapy in Canada?

Eli Lilly and Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.